Published • loading... • Updated
Weight-loss marketing in China is selling drugs it can’t name
Summary by Dao Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Weight-loss marketing in China is selling drugs it can’t name
Weight-loss drug marketing in China: Key takeaways China’s prescription-drug advertising ban has pushed pharma brands towards disease-awareness campaigns that avoid naming treatments Innovent, Lilly, Pfizer and Novo Nordisk use mascots, metro ads, fitness events and health education to reach consumers before diagnosis The strategy carries legal risk because China’s Advertising Law also covers indirect product promotion In Shanghai’s metro syste…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
